See more : Knorr-Bremse Aktiengesellschaft (KBX.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Saudi Pharmaceutical Industries and Medical Appliances Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Viking Line Abp (VKGLF) Income Statement Analysis – Financial Results
- VisasQ Inc. (4490.T) Income Statement Analysis – Financial Results
- Arrowhead Pharmaceuticals, Inc. (ARWR) Income Statement Analysis – Financial Results
- HempAmericana, Inc (HMPQ) Income Statement Analysis – Financial Results
- Menif – Financial Services Ltd (MNIF.TA) Income Statement Analysis – Financial Results
Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.spimaco.com.sa
About Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; and wholesale and retail of medicines and related products. In addition, it develops, manufactures, and sells pharmaceutical products and medical appliances; operates and maintains healthcare facilities. Further, the company engages in the research and development of medical science. The company was founded in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.65B | 1.43B | 1.46B | 1.56B | 1.55B | 1.27B | 1.39B | 1.84B | 1.71B | 1.47B | 1.30B | 1.24B | 1.13B | 1.04B | 950.74M | 871.94M | 797.75M | 727.84M |
| Cost of Revenue | 945.00M | 860.02M | 839.92M | 867.66M | 1.00B | 654.42M | 681.58M | 931.81M | 872.95M | 675.65M | 595.10M | 564.59M | 568.65M | 551.42M | 532.37M | 510.66M | 472.51M | 419.42M |
| Gross Profit | 708.08M | 566.32M | 619.87M | 691.82M | 550.75M | 620.40M | 704.46M | 909.38M | 832.10M | 794.54M | 701.52M | 680.32M | 560.57M | 486.22M | 418.37M | 361.28M | 325.23M | 308.42M |
| Gross Profit Ratio | 42.83% | 39.70% | 42.46% | 44.36% | 35.47% | 48.67% | 50.83% | 49.39% | 48.80% | 54.04% | 54.10% | 54.65% | 49.64% | 46.86% | 44.01% | 41.43% | 40.77% | 42.37% |
| Research & Development | 36.72M | 42.65M | 8.07M | 20.41M | 32.06M | 34.88M | 33.36M | 30.03M | 2.72M | 2.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 76.33M | 80.82M | 64.92M | 49.55M | 49.94M | 195.40M | 126.97M | 119.81M | 92.48M | 79.37M | 32.61M | 55.05M | 50.24M | 48.65M | 41.52M | 244.43M | 232.77M | 45.33M |
| Selling & Marketing | 95.47M | 78.22M | 71.89M | 65.30M | 150.95M | 345.47M | 356.01M | 509.16M | 477.59M | 473.22M | 247.05M | 363.15M | 318.97M | 271.93M | 231.98M | 220.08M | 190.97M | 159.80M |
| SG&A | 604.00M | 159.04M | 136.82M | 114.84M | 200.89M | 510.35M | 478.09M | 545.44M | 570.07M | 552.59M | 279.66M | 418.21M | 369.21M | 320.57M | 273.51M | 464.50M | 423.74M | 205.13M |
| Other Expenses | -14.19M | 476.34M | 434.40M | 408.18M | 414.73M | 7.06M | -511.00M | 276.81M | 1.75M | 2.27M | 4.15M | 0.00 | 5.62M | 2.83M | -3.01M | 23.12M | 12.27M | 7.63M |
| Operating Expenses | 645.00M | 678.03M | 579.28M | 543.44M | 647.68M | 538.16M | -511.00M | 276.81M | 570.07M | 552.59M | 492.37M | 418.21M | 374.83M | 323.41M | 270.49M | 487.63M | 436.01M | 212.75M |
| Cost & Expenses | 1.59B | 1.54B | 1.42B | 1.41B | 1.65B | 654.42M | 681.58M | 931.81M | 1.44B | 1.23B | 1.09B | 982.80M | 943.48M | 874.82M | 802.86M | 998.29M | 908.53M | 632.17M |
| Interest Income | 0.00 | 35.30M | 31.40M | 26.61M | 32.64M | 2.15M | 4.55M | 0.00 | 0.00 | 0.00 | 0.00 | 57.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 59.23M | 35.30M | 31.40M | 33.44M | 41.04M | 0.00 | 14.72M | 26.93M | 2.83M | 2.56M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 78.55M | 88.82M | 88.11M | 87.42M | 101.87M | 53.00M | 41.04M | 25.73M | 235.39M | 99.98M | 30.92M | 21.94M | 21.84M | -7.44M | 29.73M | 29.64M | 18.62M | 15.93M |
| EBITDA | 173.97M | -13.46M | 142.64M | 241.95M | -290.94M | 162.57M | 251.56M | 369.13M | 378.93M | 374.25M | 332.14M | 292.52M | 207.58M | 162.82M | 177.61M | -96.71M | -92.16M | 111.59M |
| EBITDA Ratio | 10.52% | -0.94% | 9.04% | 17.75% | -13.58% | 3.23% | 19.11% | 23.74% | 29.17% | 23.26% | 25.34% | 22.82% | 17.89% | 15.42% | 19.00% | -13.05% | -13.09% | 14.28% |
| Operating Income | 89.40M | -111.71M | 43.92M | 153.17M | -96.93M | 620.40M | 193.46M | 160.30M | 262.03M | 241.94M | 206.93M | 200.35M | 214.95M | 190.96M | 170.34M | -107.56M | -97.13M | 103.29M |
| Operating Income Ratio | 5.41% | -7.83% | 3.01% | 9.82% | -6.24% | 48.67% | 13.96% | 8.71% | 15.37% | 16.46% | 15.96% | 16.09% | 19.04% | 18.40% | 17.92% | -12.34% | -12.18% | 14.19% |
| Total Other Income/Expenses | -53.21M | -20.88M | -21.77M | -33.24M | -154.70M | 28.54M | 56.74M | 165.31M | 114.07M | 97.42M | 79.77M | 50.84M | 23.59M | 25.13M | 24.25M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 36.18M | -145.25M | 33.73M | 157.97M | -449.39M | 12.63M | 250.20M | 410.18M | 376.10M | 339.36M | 286.32M | 251.20M | 214.95M | 190.96M | 170.34M | -107.56M | -97.13M | 103.29M |
| Income Before Tax Ratio | 2.19% | -10.18% | 2.31% | 10.13% | -28.95% | 0.99% | 18.05% | 22.28% | 22.06% | 23.08% | 22.08% | 20.18% | 19.04% | 18.40% | 17.92% | -12.34% | -12.18% | 14.19% |
| Income Tax Expense | 45.26M | 24.98M | 12.35M | 43.90M | 31.68M | -90.20M | 52.83M | 33.49M | 19.05M | 22.51M | 110.27M | 80.32M | -31.31M | -9.10M | -3.91M | -271.71M | -244.92M | -11.11M |
| Net Income | -13.71M | -170.23M | 26.45M | 124.79M | -481.07M | 102.83M | 197.37M | 376.69M | 357.05M | 316.85M | 266.82M | 232.63M | 211.43M | 176.52M | 154.80M | 128.27M | 121.86M | 99.15M |
| Net Income Ratio | -0.83% | -11.93% | 1.81% | 8.00% | -30.99% | 8.07% | 14.24% | 20.46% | 20.94% | 21.55% | 20.58% | 18.69% | 18.72% | 17.01% | 16.28% | 14.71% | 15.28% | 13.62% |
| EPS | -0.11 | -1.42 | 0.22 | 1.04 | -4.01 | 0.86 | 1.64 | 3.14 | 2.98 | 2.94 | 2.22 | 1.94 | 1.76 | 1.47 | 1.69 | 1.40 | 1.33 | 1.08 |
| EPS Diluted | -0.11 | -1.42 | 0.22 | 1.04 | -4.01 | 0.86 | 1.64 | 3.14 | 2.98 | 2.94 | 2.22 | 1.94 | 1.76 | 1.47 | 1.69 | 1.40 | 1.33 | 1.08 |
| Weighted Avg Shares Out | 119.97M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 107.76M | 119.96M | 119.96M | 119.99M | 119.99M | 91.79M | 91.79M | 91.79M | 91.79M |
| Weighted Avg Shares Out (Dil) | 119.97M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 107.76M | 119.99M | 119.99M | 119.99M | 119.99M | 91.79M | 91.79M | 91.79M | 91.79M |
Source: https://incomestatements.info
Category: Stock Reports